Table 3.
Index therapy change within 6 months and full study period
| Within 6 months | Across full study period | |||
|---|---|---|---|---|
| Latanoprost N = 632 |
Travoprost-Z N = 268 |
Latanoprost N = 632 |
Travoprost-Z N = 268 |
|
| Changed therapy, n % | 134 (21.2) | 77 (28.7) | 218 (34.5) | 121 (45.2) |
| p-value* | 0.0148 | 0.0026 | ||
| Hazard ratio† | 1.519 | 1.499 | ||
| p-value | 0.0035 | 0.0004 | ||
| Days to change | ||||
| Mean ± SD | 72.9 ± 51.2 | 54.1 ± 48.0 | 194.8 ± 192.9 | 178.0 ± 196.7 |
| Median | 56.5 | 40.0 | 125.0 | 90.0 |
SD = standard deviation.
*Chi-square test.
†The reference cohort is latanoprost. Based on the Cox proportional hazards model.